N Eng J MedNCT04526665PBCElafibranorliver fibrosisELA
…ful marker of disease progression.References Kowdley KV, et al. N Eng J Med. 2024;390:795–805.Kowdley, KV, et al. Hepatology. 2025;81:60.…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…ful marker of disease progression.References Kowdley KV, et al. N Eng J Med. 2024;390:795–805.Kowdley, KV, et al. Hepatology. 2025;81:60.…
…olerated in patients with PBC in the phase III ELATIVE® trial ( NCT04526665). Here, longitudinal protein expression profiles were evaluated…